Table 1 Baseline characteristics of the patients receiving cardiac resynchronisation therapy
Parameters
Age (years)63 (15)
Gender, % male80%
Aetiology of heart failure, % ischaemic41%
NYHA class, % patients
    III87%
    IV13%
Quality of life score31 (20)
6-Minute hall-walk distance (m)337 (100)
Medications, % patients:
    Diuretic95%
    ACEi or ARB90%
    β-blocker74%
    Spironolactone28%
    Nitrate31%
    Digoxin13%
  • ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin-receptor blocker; NYHA, New York Heart Association.